MedPath

Not Applicable

🇲🇺Mauritius
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

829

Active:11
Completed:186

Trial Phases

5 Phases

Phase 1:18
Phase 2:46
Phase 3:35
+2 more phases

Drug Approvals

10

NPRA:10

Drug Approvals

THREE LEGS COOLING WATER

Approval Date
Jul 7, 2025
Company
SYARIKAT WEN KEN DRUG SDN. BHD.
NPRA

PVP-TYLOSIN 20% w/w POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

PVP-TIAMULIN 10% w/w POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

ACUGRAIN TABLET 0.5MG

Approval Date
Jul 4, 2025
Company
duopharma (m) sendirian berhad
NPRA

EU YAN SANG LOK MEI PA PLUS PILLS

Approval Date
Jul 4, 2025
Company
eu yan sang (1959) sdn.bhd.
NPRA

PVP-AMPROLIUM 20% w/w POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

Visal Capsule

Approval Date
Jul 4, 2025
Company
SYARIKAT WEN KEN DRUG SDN. BHD.
NPRA

PDP-CTC 20% w/w POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

PVP-CEFADROXIL 15% w/w SOLUBLE POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

PVP-OXYTETRACYCLINE 20% w/w POWDER

Approval Date
Jul 4, 2025
Company
pelangi vet pharma sdn. bhd.
NPRA

Clinical Trials

Distribution across different clinical trial phases (457 trials with phase data)• Click on a phase to view related trials

Not Applicable
307 (67.2%)
Phase 2
46 (10.1%)
Phase 4
44 (9.6%)
Phase 3
35 (7.7%)
Phase 1
18 (3.9%)
phase_2_3
4 (0.9%)
phase_1_2
3 (0.7%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.